Published in Mayo Clin Proc on October 01, 1968
On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates. J Physiol (1980) 1.34
The effects of tetanus toxin on neuromuscular transmission and on the morphology of motor end-plates in slow and fast skeletal muscle of the mouse. J Physiol (1973) 1.29
4-aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome. J Neurol Neurosurg Psychiatry (1977) 1.17
Effects of guanidine on transmitter release and neuronal excitability. J Physiol (1977) 1.01
A study of sensitivity to curare in myasthenic disorders using a regionaltechnique. J Neurol Neurosurg Psychiatry (1975) 0.93
Presynaptic Active Zone Density during Development and Synaptic Plasticity. Front Mol Neurosci (2012) 0.88
Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission. J Physiol (2002) 0.88
Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies. J Bioenerg Biomembr (2003) 0.87
Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome. J Physiol (1995) 0.85
Novel drug of choice in Eaton-Lambert syndrome. J Neurol Neurosurg Psychiatry (1983) 0.84
Cephalic tetanus studied with single fibre EMG. J Neurol Neurosurg Psychiatry (1983) 0.84
Lambert-Eaton sera reduce low-voltage and high-voltage activated Ca2+ currents in murine dorsal root ganglion neurons. Proc Natl Acad Sci U S A (1996) 0.84
Lambert-Eaton myasthenic syndrome. Postgrad Med J (1999) 0.81
Effect of temperature on neuromuscular transmission in the Eaton-Lambert syndrome. J Neurol Neurosurg Psychiatry (1979) 0.81
Myasthenia gravis and the myasthenic syndrome. Calif Med (1970) 0.80
Immunocytochemical characteristics of small cell lung carcinoma associated with the Lambert-Eaton myasthenic syndrome. Am J Pathol (1992) 0.78
Abnormalities of autonomic function in the Lambert Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry (1988) 0.78
Cancer-associated myasthenic (Eaton-Lambert) syndrome: distribution of abnormality and effect of treatment. J Neurol Neurosurg Psychiatry (1984) 0.78
Myasthenic syndrome: effect of choline, plasmapheresis and tests for circulating factor. J Neurol Neurosurg Psychiatry (1980) 0.78
Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine. J Neurol Neurosurg Psychiatry (1980) 0.77
The role of laminins in the organization and function of neuromuscular junctions. Matrix Biol (2016) 0.76
Autoimmune channelopathies of the nervous system. Curr Neuropharmacol (2011) 0.76
Guanidine hydrochloride therapy in neuromuscular disorders. West J Med (1975) 0.75
Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings. J Physiol (1998) 0.75
New Ideas about Myasthenia Gravis. Calif Med (1970) 0.75
The effect of guanidine on transmitter release in the ciliary ganglion of the chick. J Physiol (1978) 0.75
Recurrent lobar pneumonia associated with idiopathic Eaton-Lambert syndrome. Thorax (1988) 0.75
Paraneoplastic syndromes of the nervous system. West J Med (1985) 0.75
John Newsom-Davis: clinician-scientist and so much more. Brain (2011) 0.75
A quantitative study of end-plate potentials in isolated human muscle. J Physiol (1965) 5.01
Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol (1968) 3.80
Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol (1968) 3.48
Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc (1971) 3.35
Polyneuropathy associated with hypothyroidism. J Neuropathol Exp Neurol (1970) 2.95
The accessory deep peroneal nerve. A common variation in innervation of extensor digitorum brevis. Neurology (1969) 2.75
Quantal components of end-plate potentials in the myasthenic syndrome. Ann N Y Acad Sci (1971) 2.73
Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol (1981) 2.36
Calcium dependence of spontaneous acetylcholine release at mammalian motor nerve terminals. J Physiol (1965) 2.34
Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med (1995) 2.32
Spontaneous activity at a mammalian neuromuscular junction in tetrodotoxin. Acta Physiol Scand (1965) 2.21
The exercise test in periodic paralysis. Muscle Nerve (1986) 1.88
Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc (1977) 1.85
Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology (1977) 1.78
The spectrum and diagnosis of acid maltase deficiency. Neurology (1973) 1.71
Long-term results of operation for carpal tunnel syndrome. Mayo Clin Proc (1966) 1.70
Dissociated sensation in amylidosis. Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies. Arch Neurol (1969) 1.70
Course of dermatomyositis-polymyositis: comparison of untreated and cortisone-treated patients. Mayo Clin Proc (1968) 1.67
Defects of neuromuscular transmission in syndromes other than myasthenia gravis. Ann N Y Acad Sci (1966) 1.65
Withdrawal of antiepileptic medication in children--effects on cognitive function: The Multicenter Holmfrid Study. Neurology (1993) 1.58
Pain in peripheral neuropathy related to rate and kind of fiber degeneration. Neurology (1976) 1.53
Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies. J Exp Med (1976) 1.53
A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann Neurol (1982) 1.52
Sleep in the surgical intensive care unit: continuous polygraphic recording of sleep in nine patients receiving postoperative care. Br Med J (Clin Res Ed) (1985) 1.46
Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature (1980) 1.38
A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release. Ann Neurol (1977) 1.36
Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis. J Neuropathol Exp Neurol (1980) 1.35
Effects of sodium pump inhibitors on spontaneous acetylcholine release at the neuromuscular junction. J Physiol (1965) 1.33
Interstitial hyperosmolarity may cause axis cylinder shrinkage in streptozotocin diabetic nerve. J Neuropathol Exp Neurol (1980) 1.31
Hereditary sensory neuropathy, type II. Clinical, electrophysiologic, histologic, and biochemical studies of a Quebec kinship. Arch Neurol (1973) 1.29
Not 'indifference to pain' but varieties of hereditary sensory and autonomic neuropathy. Brain (1983) 1.29
Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome. Neurology (1978) 1.28
Autoimmunity in the Lambert-Eaton myasthenic syndrome. Muscle Nerve (1982) 1.28
Electrodiagnostic aspects of the carpal tunnel syndrome. Arch Neurol (1967) 1.25
Linkage evidence for genetic heterogeneity among kinships with hereditary motor and sensory neuropathy, type I. Mayo Clin Proc (1983) 1.24
Histometric study of neuromuscular junction ultrastructure. I. Myasthenia gravis. Neurology (1972) 1.24
Motor end-plate fine structure in acrylamide dying-back neuropathy: a sequential morphometric study. Neurology (1974) 1.21
End-plate potentials in experimental autoimmune myasthenia gravis in rats. Ann N Y Acad Sci (1976) 1.21
Severe hypomyelination and marked abnormality of conduction in Dejerine-Sottas hypertrophic neuropathy: myelin thickness and compound action potential of sural nerve in vitro. Mayo Clin Proc (1971) 1.19
Hair cells in the inner ear of the pirouette and shaker 2 mutant mice. J Neurocytol (2000) 1.18
Autoantibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin Proc (1989) 1.16
The neuropathy of sulfatide lipidosis (metachromatic leukodystrophy). Neurology (1967) 1.13
Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc (1982) 1.12
Acute panautonomic neuropathy. Ann Neurol (1983) 1.11
Congenital myasthenic syndromes. Electroencephalogr Clin Neurophysiol Suppl (1987) 1.11
Study of long-term anticholinesterase therapy. Effects on neuromuscular transmission and on motor end-plate fine structure. Neurology (1973) 1.10
Sleep and wakefulness in normal preadolescent children. Sleep (1989) 1.08
Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis. J Neuropathol Exp Neurol (1978) 1.08
Computerized image recognition for morphometry of nerve attribute of shape of sampled transverse sections of myelinated fibers which best estimates their average diameter. J Neurol Sci (1977) 1.07
Experimental autoimmune myasthenia: clinical, neurophysiologic, and pharmacologic aspects. Ann N Y Acad Sci (1976) 1.05
Calcium activation of electrically inexcitable muscle fibers in primary hypokalemic periodic paralysis. Neurology (1969) 1.04
Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies. Proc Natl Acad Sci U S A (1985) 1.04
Lead neuropathy. 1) Morphometry, nerve conduction, and choline acetyltransferase transport: new finding of endoneurial edema associated with segmental demyelination. J Neuropathol Exp Neurol (1977) 1.03
Neurophysiologic studies of patients with Crohn's disease on long-term treatment with metronidazole. Scand J Gastroenterol (1991) 1.03
Pressures recorded in ulnar neuropathy. Acta Orthop Scand (1985) 1.03
Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis. J Immunol (1991) 1.02
Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity. Ann N Y Acad Sci (1981) 1.01
Cardiovascular and neurological function in elderly patients sustaining a fracture of the neck of the femur. J Bone Joint Surg Br (1981) 1.00
"Mouth-to-lung airway" for cardiac resuscitation. Lancet (1968) 0.99
Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations. J Neuropathol Exp Neurol (1976) 0.99
Laboratory tests in polymyositis. Arch Intern Med (1966) 0.99
The response of denervated skeletal muscle to succinylcholine. Anesthesiology (1973) 0.98
Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosine. Cancer Res (1988) 0.98
Terminology of electromyography. Electroencephalogr Clin Neurophysiol (1969) 0.98
Synaptic vesicle abnormality in familial infantile myasthenia. Neurology (1987) 0.97
Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology (1989) 0.97
Multisystem neuronal degeneration, hepatosplenomegaly, and adrenocortical deficiency associated with reduced tissue arachidonic acid. Neurology (1981) 0.97
Prolonged administration of ethanol to young, healthy volunteers: effects on biochemical, morphological and neurophysiological parameters. Acta Med Scand Suppl (1973) 0.96
Facial myokymia affecting the electroencephalogram. Mayo Clin Proc (1967) 0.96
Experience with a combined hemodialysis-renal transplantation program: neurologic aspects. Mayo Clin Proc (1966) 0.95
Acetylcholine receptors in small cell carcinomas. J Neurochem (1985) 0.95
Acute hyperosmolar hyperglycemia causes axonal shrinkage and reduced nerve conduction velocity. Exp Neurol (1981) 0.95
Influence of ionic environment on acetylcholine release from the motor nerve terminals. Acta Physiol Scand (1966) 0.94
Guanidine and neuromuscular transmission. II. Effect on transmitter release in response to repetitive nerve stimulation. Arch Neurol (1975) 0.93
Pressure and nerve lesion in the carpal tunnel. Acta Orthop Scand (1983) 0.93
Potassium induced release of transmitter at the human neuromuscular junction. Acta Physiol Scand (1965) 0.92
Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basis. Ann Neurol (1979) 0.92
Cervical root avulsion--electrophysiological analysis with electrospinogram. Case report. Scand J Plast Reconstr Surg (1977) 0.92
Age changes in conduction velocity of unmyelinated fibers. J Comp Neurol (1973) 0.91
Duchenne dystrophy: ultrastructural localization of the acetylcholine receptor and intracellular microelectrode studies of neuromuscular transmission. Neurology (1977) 0.89
Sleep and wakefulness after treatment for craniopharyngioma in childhood; influence on the quality and maturation of sleep. Neuropediatrics (1992) 0.89
Conduction in regenerating unmyelinated fibres. Brain (1972) 0.89
Oxygen desaturation during sleep and exercise in patients with interstitial lung disease. Thorax (1987) 0.88
Postirradiation syndrome and eeg findings in children with acute lymphoblastic leukaemia. Acta Paediatr Scand (1975) 0.87
A kinship with the Roussy-Levy syndrome. Arch Neurol (1965) 0.86
Antiepileptic drug-related cognitive complaints in seizure-free children with epilepsy before and after drug discontinuation. Epilepsia (1998) 0.86
Assessment of nerve regeneration and adaptation after median nerve reconnection and digital neurovascular flap transfer. Neurology (1988) 0.86
Endemic recurrent laryngeal nerve paresis. Correlation between EMG and stroboscopic findings. Acta Otolaryngol (1973) 0.86
Experimental myasthenia in rabbits: biochemical, immunological, electrophysiological, and morphological aspects. Ann N Y Acad Sci (1976) 0.85
Hereditary form of sustained muscle activity of peripheral nerve origin causing generalized myokymia and muscle stiffness. Ann Neurol (1984) 0.85
Guanidine and neuromuscular transmission. I. Effect on transmitter release occurring spontaneously and in response to single nerve stimuli. Arch Neurol (1975) 0.85
Nocturnal hypoxaemia in severe scoliosis. Br J Dis Chest (1988) 0.84
Conduction in unmyelinated fibres in experimental neuropathy. J Neurol Neurosurg Psychiatry (1972) 0.84
Contractile smooth muscle cell apoptosis early after saphenous vein grafting. Ann Thorac Surg (2000) 0.84
Alternate-day prednisone: preliminary report of a double-blind controlled study. Ann N Y Acad Sci (1976) 0.84
Sleep and wakefulness in preadolescent children with deficits in attention, motor control and perception. Acta Paediatr (1992) 0.83
Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors. Muscle Nerve (1985) 0.82
Dissociated sensation in amyloidosis: compound action potentials; quantitative histologic and teased fibers; and electron microscopic studies of sural nerve biopsies. Trans Am Neurol Assoc (1968) 0.82